- Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia2007 | 2. lékařská fakulta
- Survey of CMV management in pediatric allogeneic HSCT programs, on behalf of the Inborn Errors, Infectious Diseases and Pediatric Diseases Working Parties of EBMT2014 | 2. lékařská fakulta
- The importance of Therapeutic Drug Monitoring (TDM) for parenteral busulfan dosing in conditioning regimen for Hematopoietic Stem Cell Transplantation (HSCT) in children2014 | 2. lékařská fakulta
- The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: An analysis of 96 allografted AML patients >= 50 years from the Czech acute leukaemia clinical register (alert)2013 | Ústřední knihovna, Lékařská fakulta v Plzni, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group2003 | Fakulta tělesné výchovy a sportu, 1. lékařská fakulta
- HSCT from partially matched alternative donorsPublikace bez příslušnosti k fakultě
- Fanconi anemia in the Czech Republic: Role of HSCT and long-term follow-up2020 | 2. lékařská fakulta
- Biochemické markery a hodnocení kardiotoxicity v průběhu transplantace +1Publikace bez příslušnosti k fakultě
- Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience2016 | 2. lékařská fakulta
- INVARIANT NKT CELLS CULTURED IN IL2 OR IL15 COULD BE USED AS REGULATORS OF POST-TRANSPLANT COMPLICATIONSPublikace bez příslušnosti k fakultě
- Single-Nucleotide Polymorphisms in MICA and MICB Genes Could Play a Role in the Outcome in AML Patients after HSCT2021 | Lékařská fakulta v Plzni
- Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party2011 | Fakulta tělesné výchovy a sportu
- Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study2020 | 2. lékařská fakulta
- HSCT from partially matched alternative donors : a single centre experiencePublikace bez příslušnosti k fakultě
- Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters2016 | 2. lékařská fakulta
- Clinical and genotypic CMV drug resistance in HSCT recipients: a single center epidemiological and clinical data2019 | Lékařská fakulta v Hradci Králové, 2. lékařská fakulta
- Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial2005 | 2. lékařská fakulta
- Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial2018 | 2. lékařská fakulta
- Dynamic Changes of Inhibitory Killer-Immunoglobulin-Like Receptors on NK Cells after Allogeneic Hematopoietic Stem Cell Transplantation: An Initial Study2020 | Lékařská fakulta v Plzni, 1. lékařská fakulta
- Low rate of nonrelapse mortality in under 4-year-olds with ALL given chemo-conditioning for HSCT: Phase III FORUM study2024 | 2. lékařská fakulta
- Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes2018 | 2. lékařská fakulta
- Second Hematopoietic Stem Cell Transplantation for Post-Transplantation Relapsed Acute Leukemia in Children: A Retrospective EBMT-PDWP Study2018 | 2. lékařská fakulta
- Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: development, recent activity and role of the EBMT/ESH Outreach Programme2008 | 2. lékařská fakulta
- Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood2020 | 2. lékařská fakulta
- Disappearance of pre-existing high HHV-6 DNA load in blood after allogeneic SCT2007 | Fakulta tělesné výchovy a sportu, 1. lékařská fakulta, 2. lékařská fakulta
- Pretransplant bk virus-specific t-cell-mediated immunity and serotype specific antibodies may have utility in identifying patients at risk of bk virus-associated haemorrhagic cystitis after allogeneic hsct2021 | 2. lékařská fakulta, Přírodovědecká fakulta
- ATG (Fresenius) 20 mg/kg b.w. + CSA is sufficent GvHD prophylactic regimen for fully matched related and unrelated HSCT, while 40 mg/kg b.w. of ATG + CSA and MMF should be used for partially matched HSCT : a single-centre experiencePublikace bez příslušnosti k fakultě
- Quality of Life of Oncological and Hematooncological Patients after the HSCT: Finding from Cross-sectional and Retrospective StudyPublikace bez příslušnosti k fakultě
- Rekonstituce dendritických buněk po myeloablativní alogenní transplantaci kmenových buněk krvetvorby a její poruchy u akutní GVHD2010 | Fakulta tělesné výchovy a sportu, 1. lékařská fakulta, 2. lékařská fakulta